Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 18 to 60 years.~* BMI between 25 and 29,9 kg/m².~* Weight variance less than 5% in the last 3 months.~* Previous diagnosis of diabetes type 2.~* Insulin requirement, alone or along with oral agents~* Capacity to understand the procedures of the study.~* To agree voluntarily to participate of the study, signing an informed consent.~Exclusion Criteria:~* Positive Anti-GAD antibodies~* Laboratorial signal of probable failure of insulin production, i. e., seric peptide C lesser than 1 ng/mL.~* History of hepatic disease like cirrhosis or chronic active hepatitis.~* Kidney dysfunction (creatinine \> 1,4 mg/dl in women and \> 1,5 mg/dl in men).~* Hepatic dysfunction: ALT and/or AST 3x above upper normal limit.~* Recent history of neoplasia (\< 5 years).~* Use of oral or injectable corticosteroids for more than consecutive 14 days in the last three months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Duodenal exclusion plus total omentectomy
- 2 (Type: ACTIVE_COMPARATOR): Duodenal exclusion without omentectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).